zSCAI Representative. xACC/AHA Task Force on Clinical Practice Guidelines Liaison. STEMI Writing Committee* Patrick T. O Gara, MD, FACC, FAHA, Chairy Frederick G. Kushner, MD, FACC, FAHA, FSCAI, Vice Chairy Deborah D. Ascheim, MD, FACCk Ralph G. Brindis, MD, MPH, MACC, FSCAI, FAHAx Donald E. Casey, JR, MD, MPH, MBA, FAHA{ Mina K. Chung, MD, FACC, FAHA*y James A. de Lemos, MD, FACC*y Deborah B. Diercks, MD, MSc# James C. Fang, MD, FACC, FAHA*y Barry A. Franklin, PhD, FAHAy Christopher B. Granger, MD, FACC, FAHA*y Harlan M. Krumholz, MD, SM, FACC, FAHA*y Jane A. Linderbaum, MS, CNP-BCy David A. Morrow, MD, MPH, FACC, FAHA*y L. Kristin Newby, MD, MHS, FACC, FAHA*y Joseph P. Ornato, MD, FACC, FAHA, FACP, FACEP*y Narith Ou, PharmDy Martha J. Radford, MD, FACC, FAHAy Jacqueline E. Tamis-Holland, MD, FACC, FSCAIy Carl L. Tommaso, MD, FACC, FAHA, MSCAIz Cynthia M. Tracy, MD, FACC, FAHAy Y. Joseph Woo, MD, FACC, FAHAy David X. Zhao, MD, FACC*y kDr. Deborah D. Ascheim accepted a position at Capricor Therapeutics in August 2015, after the writing effort was completed. In accordance with ACC/AHA policy, she recused herself from the nal voting process. {ACP Representative. #ACEP Representative. J O U R N A L O F T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y V O L . 6 7 , N O . 